Singapore’s Infocomm Media Development Authority ... security and resilience in the industry.” Bill Chang, CEO of Nxera, Singtel’s datacentre arm, welcomed the new guidelines, adding ...

Nxera Pharma Co., Ltd. announces that it has entered a license, supply and commercialization agreement with Holling Bio-Pharma Corp. (Holling) for daridorexant in Taiwan. Daridorexant is an oral dual ...

The agreement was signed concurrently with Nxera’s assignment of its option to these same rights from Idorsia Pharmaceuticals Ltd under its agreement in July 2023 to acquire Idorsia Pharmaceuticals ...

Under the terms of the agreement, Nxera will be responsible for the supply of drug product and Holling will be responsible for regulatory, commercial and distribution activities and will hold all ...

The agreement was signed concurrently with Nxera’s assignment of its option to these same rights from Idorsia Pharmaceuticals Ltd under its agreement in July 2023 to acquire Idorsia ...

Nxera Pharma has sold the Asia-Pacific rights to Idorsia's phase 3-stage autoimmune drug to Viatris for $10 million upfront. The drug in question is cenerimod, a S1P1 receptor modulator currently ...

Under the terms of the agreement, Nxera will be responsible for the supply of drug product and Holling will be responsible for regulatory, commercial and distribution activities and will hold all ...